dihexa human trial clinical studies trials Dihexa dihexa human clinical trials data – dihexa clinical trials status trial

BPC157 (Body Protection Compound157) is a synthetic peptide fragment derived from a protective gastric protein

Users have reported side effects such as injection site reactions, fatigue, headaches, and gastrointestinal issues

PSPeptides meets all of the above standards for research-grade supply: third-party HPLC purity testing at 99%+, MS confirmation of molecular weight, US-based synthesis, and same-day shipping with full CoA documentation included

Cold storage is non-negotiable

Prioritize recovery: AOD 9604 can improve recovery somewhat, but adequate sleep (7-9 hours), stress management, and strategic deload weeks are still important

Now, wellness business insiders are left scratching their heads on how to approach this cultural shift